淋巴瘤表观遗传学靶向治疗的进展
苗昭艺， 赵智刚 - 中国肿瘤临床, 2020 - cjco.cn
… -Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study
[J]. … Anti-tumor activity of the typeⅠ PRMT inhibitor, GSK3368715, synergizes with PRMT5 …
[J]. … Anti-tumor activity of the typeⅠ PRMT inhibitor, GSK3368715, synergizes with PRMT5 …